0.5500
25-نوفمبر-24 15:45:01
15 متأخرة بدقائق
الأسهم
9.9999999999989E-05
+0.02%
نطاق اليوم
0.5410 - 0.5728
ISIN
N/A
المصدر
NASDAQ
AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina
08 نوفمبر 2024 05:00:00 بحسب Nasdaq GlobeNewswire
AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy
22 ديسمبر 2023 06:00:00 بحسب Nasdaq GlobeNewswire